{
    "hands_on_practices": [
        {
            "introduction": "Interstitial lung diseases are fundamentally 'restrictive' diseases, a term that describes the mechanical consequences of fibrosis. This exercise provides a direct way to quantify this restriction by calculating lung compliance, the measure of the lung's stretchiness. By comparing the compliance of a fibrotic lung to a healthy one, you can appreciate the profound impact of interstitial scarring on lung mechanics .",
            "id": "4393196",
            "problem": "A patient with biopsy-proven idiopathic pulmonary fibrosis (IPF) undergoes a quasi-static pressure–volume maneuver near functional residual capacity (FRC). Between two equilibrated points on the inspiratory limb, the measured change in lung volume is $\\Delta V = 0.4$ L for a change in transpulmonary pressure of $\\Delta P = 8$ cmH$_2$O. In the small-signal, quasi-static regime, static compliance is defined as the ratio of change in volume to change in pressure, and increased parenchymal stiffness corresponds to decreased compliance. For a healthy adult at similar lung volumes, assume a representative static compliance of $C_{\\text{normal}} = 0.2 \\text{ L}/\\text{cmH}_2\\text{O}$.\n\nUnder a linear, small-deformation approximation where stiffness scales inversely with compliance, define the stiffness multiplier as $S = \\dfrac{C_{\\text{normal}}}{C_{\\text{patient}}}$, where $C_{\\text{patient}}$ is the patient’s static compliance computed from the measurement above.\n\nCompute $S$. Report your final answer as a single pure number (no units). Provide the exact value; no rounding is required.",
            "solution": "The problem statement has been critically reviewed and is deemed valid. It is scientifically grounded in the principles of respiratory physiology, well-posed with sufficient and consistent data, and objectively formulated. The values provided are physiologically plausible for the conditions described. We may therefore proceed with the solution.\n\nThe problem asks for the calculation of a stiffness multiplier, $S$, for a patient with idiopathic pulmonary fibrosis (IPF). This is to be done by comparing the patient's measured static lung compliance to a representative normal value.\n\nFirst, we calculate the patient's static compliance, denoted as $C_{\\text{patient}}$. The problem defines static compliance, $C$, in the small-signal, quasi-static regime as the ratio of the change in lung volume, $\\Delta V$, to the corresponding change in transpulmonary pressure, $\\Delta P$.\nThe formula is given as:\n$$\nC = \\frac{\\Delta V}{\\Delta P}\n$$\nThe givens for the patient are:\n- Change in lung volume, $\\Delta V = 0.4$ L.\n- Change in transpulmonary pressure, $\\Delta P = 8 \\text{ cmH}_2\\text{O}$.\n\nSubstituting these values into the compliance formula, we compute the patient's static compliance:\n$$\nC_{\\text{patient}} = \\frac{0.4 \\text{ L}}{8 \\text{ cmH}_2\\text{O}}\n$$\nPerforming the division gives:\n$$\nC_{\\text{patient}} = 0.05 \\text{ L}/\\text{cmH}_2\\text{O}\n$$\nThis value is consistent with the pathophysiology of IPF, which is a restrictive lung disease characterized by increased lung stiffness and, consequently, decreased compliance.\n\nNext, the problem defines a dimensionless stiffness multiplier, $S$, as the ratio of the normal static compliance, $C_{\\text{normal}}$, to the patient's static compliance, $C_{\\text{patient}}$. The relationship is based on the approximation that stiffness is inversely proportional to compliance.\nThe formula for the stiffness multiplier is:\n$$\nS = \\frac{C_{\\text{normal}}}{C_{\\text{patient}}}\n$$\nThe problem provides the representative value for normal static compliance:\n- Normal static compliance, $C_{\\text{normal}} = 0.2 \\text{ L}/\\text{cmH}_2\\text{O}$.\n\nWe can now substitute the known values of $C_{\\text{normal}}$ and our calculated value of $C_{\\text{patient}}$ into the formula for $S$:\n$$\nS = \\frac{0.2 \\text{ L}/\\text{cmH}_2\\text{O}}{0.05 \\text{ L}/\\text{cmH}_2\\text{O}}\n$$\nThe units of L/cmH$_2$O in the numerator and denominator cancel out, rendering $S$ a dimensionless quantity as required.\nThe numerical calculation is:\n$$\nS = \\frac{0.2}{0.05} = \\frac{20}{5} = 4\n$$\nThus, the stiffness multiplier is $4$. This indicates that, under the given linear approximation and at the specified lung volume, the fibrotic lung parenchyma of the patient is approximately $4$ times stiffer than that of a healthy adult.",
            "answer": "$$\\boxed{4}$$"
        },
        {
            "introduction": "Beyond stiffening the lung, fibrosis also impairs its primary function: gas exchange. This practice uses Fick's law of diffusion as a model to explore how the thickening of the alveolar-capillary membrane directly impedes the transfer of gases. You will calculate the effect of a thickened diffusion barrier on the Diffusing Capacity for Carbon Monoxide ($DLCO$), a key clinical measurement for assessing ILD severity .",
            "id": "4393191",
            "problem": "A patient with idiopathic pulmonary fibrosis (IPF) has progressive collagen deposition that increases the thickness of the alveolar–capillary membrane. Consider the diffusive transfer of carbon monoxide (CO) across this membrane during standardized testing of Diffusing Capacity for Carbon Monoxide (DLCO). Assume the following fundamental basis: according to Fick’s law of diffusion, the rate of gas transfer across a membrane, $V_{\\text{gas}}$, is proportional to the product of membrane area $A$, the gas diffusion coefficient $D$, and the partial pressure difference $(P_{1} - P_{2})$, and inversely proportional to membrane thickness $T$. In this patient, the interstitial thickness increases from $T$ to $2T$, while $A$, $D$, and $(P_{1} - P_{2})$ remain unchanged, and the hemoglobin reaction kinetics and capillary recruitment are unchanged so that DLCO scales directly with the structural diffusion limit set by $T$. Using these assumptions, compute the percent decrease in DLCO due solely to the doubling of $T$. Express your final answer as a decimal (for example, $0.25$), with no percent sign and no units.",
            "solution": "The problem statement is evaluated as valid. It is scientifically grounded in the principles of respiratory physiology and physics (Fick's law of diffusion), providing a self-contained and well-posed question. The assumptions, such as holding membrane area constant to isolate the effect of thickness, are standard for this type of analysis.\n\nThe problem asks for the percent decrease in the Diffusing Capacity for Carbon Monoxide ($DLCO$) when the alveolar-capillary membrane thickness doubles. According to the problem statement, Fick's law of diffusion governs the rate of gas transfer, $V_{\\text{gas}}$, across the membrane. This relationship is given as:\n$$V_{\\text{gas}} \\propto \\frac{A \\cdot D \\cdot (P_{1} - P_{2})}{T}$$\nwhere $A$ is the membrane area, $D$ is the gas diffusion coefficient, $(P_{1} - P_{2})$ is the partial pressure difference across the membrane, and $T$ is the membrane thickness.\n\nWe can express this proportionality as an equation with a constant of proportionality, $k$:\n$$V_{\\text{gas}} = k \\frac{A \\cdot D \\cdot (P_{1} - P_{2})}{T}$$\n\nThe diffusing capacity of the lung for a gas, in this case $DLCO$, is defined as the rate of gas transfer divided by the partial pressure difference driving the transfer:\n$$DLCO = \\frac{V_{\\text{gas}}}{P_{1} - P_{2}}$$\n\nSubstituting the expression for $V_{\\text{gas}}$ from Fick's law into the definition of $DLCO$, we obtain:\n$$DLCO = \\frac{k \\frac{A \\cdot D \\cdot (P_{1} - P_{2})}{T}}{P_{1} - P_{2}} = \\frac{k \\cdot A \\cdot D}{T}$$\nThis derivation is consistent with the problem's assumption that \"$DLCO$ scales directly with the structural diffusion limit set by $T$\". The problem states that $A$ and $D$ remain unchanged. The constant $k$ is also a constant. Therefore, we can group these constants into a single constant, $C = k \\cdot A \\cdot D$. The relationship simplifies to:\n$$DLCO = \\frac{C}{T}$$\nThis equation shows that $DLCO$ is inversely proportional to the membrane thickness $T$.\n\nLet the initial state of the patient be denoted by subscript $1$. The initial thickness is $T_{1} = T$, and the initial diffusing capacity is $DLCO_{1}$:\n$$DLCO_{1} = \\frac{C}{T_{1}} = \\frac{C}{T}$$\n\nIn the diseased state, the thickness of the membrane doubles. Let this final state be denoted by subscript $2$. The final thickness is $T_{2} = 2T$. The final diffusing capacity is $DLCO_{2}$:\n$$DLCO_{2} = \\frac{C}{T_{2}} = \\frac{C}{2T}$$\n\nTo find the new $DLCO$ value relative to the original, we can compute the ratio of $DLCO_{2}$ to $DLCO_{1}$:\n$$\\frac{DLCO_{2}}{DLCO_{1}} = \\frac{\\frac{C}{2T}}{\\frac{C}{T}} = \\frac{C}{2T} \\cdot \\frac{T}{C} = \\frac{1}{2}$$\nThis shows that $DLCO_{2} = \\frac{1}{2} DLCO_{1}$. The diffusing capacity is reduced to half of its original value.\n\nThe question asks for the percent decrease in $DLCO$. The fractional decrease is calculated as the absolute decrease divided by the original value:\n$$\\text{Fractional Decrease} = \\frac{DLCO_{1} - DLCO_{2}}{DLCO_{1}}$$\nSubstituting $DLCO_{2} = \\frac{1}{2}DLCO_{1}$ into this expression:\n$$\\text{Fractional Decrease} = \\frac{DLCO_{1} - \\frac{1}{2}DLCO_{1}}{DLCO_{1}} = \\frac{\\frac{1}{2}DLCO_{1}}{DLCO_{1}} = \\frac{1}{2}$$\nThe fractional decrease is $\\frac{1}{2}$. To express this as a percentage, one would multiply by $100$, yielding a $50\\%$ decrease. The problem requests the answer as a decimal. The decimal equivalent of $\\frac{1}{2}$ is $0.5$.",
            "answer": "$$\\boxed{0.5}$$"
        },
        {
            "introduction": "While many ILDs share the common pathophysiological features of restriction and impaired diffusion, they are a diverse group of diseases with distinct causes and patterns. High-Resolution Computed Tomography (HRCT) is essential for differentiating them by revealing these patterns. This final practice puts you in the role of a clinical detective, using key radiologic findings to build a diagnostic decision tree and classify major ILD subtypes, moving from general principles to the art of differential diagnosis .",
            "id": "4393195",
            "problem": "A radiology-pathology team is building a simple rule-based classifier to distinguish among four interstitial lung disease patterns on High-Resolution Computed Tomography (HRCT): Usual Interstitial Pneumonia (UIP), Nonspecific Interstitial Pneumonia (NSIP), Hypersensitivity Pneumonitis (HP), and sarcoidosis. They will limit the decision rules to three ($3$) binary HRCT descriptors grounded in anatomic-pathologic correlations:\n\n- Honeycombing present versus absent.\n- Predominant distribution perilymphatic in the upper lobes and along bronchovascular bundles/fissures versus not.\n- Airway-centered changes present (centrilobular nodules and/or mosaic attenuation with air-trapping) versus absent.\n\nThe team agrees to construct the decision tree by querying the most disease-specific HRCT hallmark earliest, proceeding toward less specific features, and assigning a final class for any remaining cases based on the most typical residual pattern. The following foundational facts are accepted as the starting point:\n\n- UIP reflects patchy, subpleural, basilar-predominant fibrosis that culminates in honeycombing; honeycombing on HRCT corresponds to stacked subpleural cystic airspaces and is highly specific for end-stage fibrosis in UIP.\n- Sarcoidosis is a granulomatous disease with a perilymphatic distribution, tracking along bronchovascular bundles, interlobular septa, subpleural regions, and fissures, with upper-lobe predominance.\n- HP is driven by inhaled antigens causing bronchiolocentric inflammation; airway-centered changes (centrilobular nodules, mosaic attenuation, and air-trapping) are characteristic, often with mid-to-upper lung predominance.\n- NSIP manifests as temporally uniform interstitial inflammation and/or fibrosis, typically basilar-predominant ground-glass and reticulation without honeycombing.\n\nTo test any proposed tree, the team will apply it to a small HRCT dataset of eight ($8$) cases with gold-standard diagnoses established by multidisciplinary discussion. Each case is summarized as follows:\n\n- Case $1$: Honeycombing present; basal subpleural predominance; airway-centered changes absent. Gold standard: UIP.\n- Case $2$: Honeycombing present; basal subpleural predominance; airway-centered changes absent. Gold standard: UIP.\n- Case $3$: Honeycombing absent; basal subpleural predominance; airway-centered changes absent. Gold standard: NSIP.\n- Case $4$: Honeycombing absent; mid-to-upper predominance; airway-centered changes present. Gold standard: HP.\n- Case $5$: Honeycombing absent; upper-lobe perilymphatic/peribronchovascular distribution (along fissures); airway-centered changes absent. Gold standard: Sarcoidosis.\n- Case $6$: Honeycombing absent; basal subpleural predominance; airway-centered changes absent. Gold standard: NSIP.\n- Case $7$: Honeycombing absent; upper-lobe perilymphatic/peribronchovascular distribution (along fissures); airway-centered changes present. Gold standard: Sarcoidosis.\n- Case $8$: Honeycombing absent; mid-to-upper predominance; airway-centered changes present. Gold standard: HP.\n\nWhich option best satisfies both of the following: (i) orders the features from most disease-specific to least, consistent with the anatomic-pathologic correlations above, and (ii) reports the correct diagnostic accuracy on this dataset?\n\nA. Decision tree: If honeycombing present, classify UIP; else if perilymphatic upper-lobe distribution present, classify sarcoidosis; else if airway-centered changes present, classify HP; else classify NSIP. Estimated accuracy on this dataset: $8/8$ ($100\\%$).\n\nB. Decision tree: If honeycombing present, classify UIP; else if airway-centered changes present, classify HP; else if perilymphatic upper-lobe distribution present, classify sarcoidosis; else classify NSIP. Estimated accuracy on this dataset: $7/8$ ($87.5\\%$).\n\nC. Decision tree: If airway-centered changes present, classify HP; else if honeycombing present, classify UIP; else if perilymphatic upper-lobe distribution present, classify sarcoidosis; else classify NSIP. Estimated accuracy on this dataset: $6/8$ ($75\\%$).\n\nD. Decision tree: If honeycombing present, classify UIP; else if perilymphatic upper-lobe distribution present, classify sarcoidosis; else if airway-centered changes present, classify HP; else classify sarcoidosis. Estimated accuracy on this dataset: $6/8$ ($75\\%$).",
            "solution": "The problem statement is subjected to validation.\n\n**Step 1: Extract Givens**\n-   **Diseases to classify**: Usual Interstitial Pneumonia (UIP), Nonspecific Interstitial Pneumonia (NSIP), Hypersensitivity Pneumonitis (HP), and sarcoidosis.\n-   **Number of features**: $3$ binary HRCT descriptors.\n-   **Feature 1 ($F_H$)**: Honeycombing present versus absent.\n-   **Feature 2 ($F_P$)**: Predominant distribution perilymphatic in the upper lobes and along bronchovascular bundles/fissures versus not.\n-   **Feature 3 ($F_A$)**: Airway-centered changes present versus absent.\n-   **Decision Tree Construction Rules**:\n    1.  Query the most disease-specific HRCT hallmark earliest.\n    2.  Proceed toward less specific features.\n    3.  Assign a final class for any remaining cases based on the most typical residual pattern.\n-   **Anatomic-Pathologic Correlations**:\n    -   UIP: Honeycombing is \"highly specific for end-stage fibrosis in UIP\".\n    -   Sarcoidosis: A granulomatous disease with a \"perilymphatic distribution\".\n    -   HP: \"Airway-centered changes... are characteristic\".\n    -   NSIP: Manifests \"without honeycombing\".\n-   **Test Dataset**: $8$ cases with gold-standard diagnoses.\n    -   Case $1$: Honeycombing=present ($F_H=1$), Distribution=not perilymphatic ($F_P=0$), Airway-centered=absent ($F_A=0$). Gold Standard: UIP.\n    -   Case $2$: $F_H=1$, $F_P=0$, $F_A=0$. Gold Standard: UIP.\n    -   Case $3$: $F_H=0$, $F_P=0$, $F_A=0$. Gold Standard: NSIP.\n    -   Case $4$: $F_H=0$, $F_P=0$, $F_A=1$. Gold Standard: HP.\n    -   Case $5$: $F_H=0$, $F_P=1$, $F_A=0$. Gold Standard: Sarcoidosis.\n    -   Case $6$: $F_H=0$, $F_P=0$, $F_A=0$. Gold Standard: NSIP.\n    -   Case $7$: $F_H=0$, $F_P=1$, $F_A=1$. Gold Standard: Sarcoidosis.\n    -   Case $8$: $F_H=0$, $F_P=0$, $F_A=1$. Gold Standard: HP.\n-   **Task**: Identify the option that (i) correctly orders features by decreasing specificity and (ii) reports the correct accuracy.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is scientifically grounded in the established principles of thoracic radiology and pathology. The descriptions of the diseases and their corresponding HRCT findings are consistent with current medical literature. The problem is well-posed, providing a clear objective, set of rules, and a dataset for evaluation. The language is objective and the setup is self-contained and logically consistent. No flaws enumerated in the validation checklist are present.\n\n**Step 3: Verdict and Action**\nThe problem is valid. A rigorous solution will be derived.\n\n**Principle-Based Derivation**\nThe core task is to construct a decision tree according to the specified rules.\n\nFirst, we must order the features $F_H$, $F_P$, and $F_A$ from most to least disease-specific, based on the provided anatomic-pathologic correlations.\n1.  **Honeycombing ($F_H$)**: The statement that honeycombing is \"highly specific for...UIP\" uses the strongest language of specificity. This indicates that if $F_H$ is present, the diagnosis is almost certainly UIP. Therefore, $F_H$ is the most specific feature.\n2.  **Perilymphatic distribution ($F_P$)**: Sarcoidosis is described as a \"disease with a perilymphatic distribution\". This links the feature directly to the fundamental nature of the disease, indicating high specificity for sarcoidosis.\n3.  **Airway-centered changes ($F_A$)**: These changes are described as \"characteristic\" of HP. While \"characteristic\" implies a strong association, it is generally considered less definitive than \"highly specific\" or a feature that defines the disease's distribution pathologically.\n\nBased on this analysis, the correct order of features, from most to least specific, is: Honeycombing ($F_H$) $\\rightarrow$ Perilymphatic distribution ($F_P$) $\\rightarrow$ Airway-centered changes ($F_A$).\n\nSecond, we construct the decision tree based on this order.\n-   Rule 1: If Honeycombing is present ($F_H=1$), classify as UIP.\n-   Rule 2 (else): If Perilymphatic distribution is present ($F_P=1$), classify as sarcoidosis.\n-   Rule 3 (else): If Airway-centered changes are present ($F_A=1$), classify as HP.\n\nThird, we determine the classification for the final `else` branch. This branch catches all cases for which $F_H=0$, $F_P=0$, and $F_A=0$. We must assign this residual pattern to the \"most typical\" remaining disease.\n-   UIP is excluded by $F_H=0$.\n-   Sarcoidosis is largely excluded by $F_P=0$.\n-   HP is largely excluded by $F_A=0$.\n-   NSIP is described as manifesting \"without honeycombing\" and typically lacks the specific features of the other diseases. This profile perfectly matches the residual cases.\n-   Therefore, the final rule is: (else) Classify as NSIP.\n\nThe correctly constructed decision tree is:\n`If $F_H=1$ $\\rightarrow$ UIP; else if $F_P=1$ $\\rightarrow$ sarcoidosis; else if $F_A=1$ $\\rightarrow$ HP; else $\\rightarrow$ NSIP.`\n\nFinally, we calculate the accuracy of this derived tree on the $8$-case dataset.\n-   Case $1$ (UIP): $F_H=1$. Tree classifies as UIP. **Correct**.\n-   Case $2$ (UIP): $F_H=1$. Tree classifies as UIP. **Correct**.\n-   Case $3$ (NSIP): $F_H=0$, $F_P=0$, $F_A=0$. Tree classifies as NSIP. **Correct**.\n-   Case $4$ (HP): $F_H=0$, $F_P=0$, $F_A=1$. Tree classifies as HP. **Correct**.\n-   Case $5$ (Sarcoidosis): $F_H=0$, $F_P=1$. Tree classifies as sarcoidosis. **Correct**.\n-   Case $6$ (NSIP): $F_H=0$, $F_P=0$, $F_A=0$. Tree classifies as NSIP. **Correct**.\n-   Case $7$ (Sarcoidosis): $F_H=0$, $F_P=1$. Tree classifies as sarcoidosis. **Correct**.\n-   Case $8$ (HP): $F_H=0$, $F_P=0$, $F_A=1$. Tree classifies as HP. **Correct**.\n\nThe number of correctly classified cases is $8$. The accuracy is $8/8$, or $100\\%$.\n\n**Option-by-Option Analysis**\n\n**A. Decision tree: If honeycombing present, classify UIP; else if perilymphatic upper-lobe distribution present, classify sarcoidosis; else if airway-centered changes present, classify HP; else classify NSIP. Estimated accuracy on this dataset: $8/8$ ($100\\%$).**\n-   **Feature Ordering and Logic**: The tree follows the order $F_H \\rightarrow F_P \\rightarrow F_A$ and correctly assigns the residual class to NSIP. This perfectly matches our derived tree structure, which is fully consistent with the problem's construction rules.\n-   **Accuracy**: The stated accuracy is $8/8$ ($100\\%$). Our independent calculation confirms this.\n-   **Verdict**: **Correct**. This option satisfies both condition (i) and condition (ii).\n\n**B. Decision tree: If honeycombing present, classify UIP; else if airway-centered changes present, classify HP; else if perilymphatic upper-lobe distribution present, classify sarcoidosis; else classify NSIP. Estimated accuracy on this dataset: $7/8$ ($87.5\\%$).**\n-   **Feature Ordering and Logic**: The tree follows the order $F_H \\rightarrow F_A \\rightarrow F_P$. This violates the principle of querying the most specific features first, as our analysis showed $F_P$ is more specific than $F_A$.\n-   **Accuracy**: Let's test this tree. It differs from the correct tree by swapping query $2$ and $3$. The misclassification will occur for a case where $F_H=0$, $F_A=1$, and $F_P=1$. This is Case $7$ (Gold Standard: Sarcoidosis). This tree queries $F_A=1$ first and classifies it as HP, which is incorrect. All other $7$ cases are classified correctly. The accuracy is indeed $7/8$ ($87.5\\%$). While the accuracy calculation is correct for this specific tree, the tree itself is not constructed according to the problem's primary rule.\n-   **Verdict**: **Incorrect**. This option fails to satisfy condition (i) concerning the optimal ordering of features.\n\n**C. Decision tree: If airway-centered changes present, classify HP; else if honeycombing present, classify UIP; else if perilymphatic upper-lobe distribution present, classify sarcoidosis; else classify NSIP. Estimated accuracy on this dataset: $6/8$ ($75\\%$).**\n-   **Feature Ordering and Logic**: The tree follows the order $F_A \\rightarrow F_H \\rightarrow F_P$. This is a severe violation of the specificity rule, as the most specific feature, $F_H$, is not queried first.\n-   **Accuracy**: Let's test this tree. By querying $F_A=1$ first, it will classify both Case $7$ (Sarcoidosis) and Case $8$ (HP) as HP. It will also classify Case $4$ (HP) as HP. Case $7$ is a misclassification. Case $4$ and $8$ are correct. All other $5$ cases have $F_A=0$ and are passed to the next rule, where they are classified correctly. This tree misclassifies only Case $7$. The accuracy is thus $7/8$ ($87.5\\%$), not $6/8$ ($75\\%$). The accuracy claim is factually wrong.\n-   **Verdict**: **Incorrect**. This option fails condition (i) and makes a false claim about accuracy for its own proposed tree, failing condition (ii).\n\n**D. Decision tree: If honeycombing present, classify UIP; else if perilymphatic upper-lobe distribution present, classify sarcoidosis; else if airway-centered changes present, classify HP; else classify sarcoidosis. Estimated accuracy on this dataset: $6/8$ ($75\\%$).**\n-   **Feature Ordering and Logic**: The feature query order $F_H \\rightarrow F_P \\rightarrow F_A$ is correct. However, the final `else` statement classifies the residual cases ($F_H=0, F_P=0, F_A=0$) as sarcoidosis. This violates the rule to \"assign a final class for any remaining cases based on the most typical residual pattern.\" The typical pattern for sarcoidosis involves $F_P=1$. The most typical pattern for these residual findings is NSIP.\n-   **Accuracy**: This tree is identical to the correct tree (Option A) except for the final `else` rule. The cases reaching this final rule are Case $3$ and Case $6$, both of which are NSIP. This tree will misclassify both as sarcoidosis. The other $6$ cases are classified correctly. The accuracy is therefore $6/8$ ($75\\%$). The accuracy calculation is correct for this flawed tree.\n-   **Verdict**: **Incorrect**. While the feature order is correct, the tree construction violates the rule for assigning the residual class, making it a suboptimal model.\n\nBased on the comprehensive analysis, Option A is the only one that fully complies with all stated rules for tree construction and reports the correct corresponding accuracy.",
            "answer": "$$\\boxed{A}$$"
        }
    ]
}